Toes-Zoutendijk E. Interval cancers after a negative faecal immunochemical test in the first screening round in the Netherlands: results for two cut-off levels. UEG Week 2018, LB14.
Pembrolizumab plus chemo als eerstelijnsbehandeling bij gevorderde slokdarmkanker
sep 2021 | Immuuntherapie, Maag-darm-leveroncologie